Acute Porphyria Drug Database

Monograph

C10AC01 - Colestyramine
Not porphyrinogenic
NP

Rationale
Not absorbed. Occasional clinical observations of non-porphyrinogenicity.
Chemical description
Anion resin used against hypercholesterolemia. Not absorbed . Andersson, patient report (n=3): tolerated.
IPNet drug reports
Uneventful use reported in 3 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes C10A / C10AC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Colestyramine · Colestyramine suikervrij 4 g Focus, poeder voor orale suspensie · Questran · Questran, poeder voor orale suspensie 4 g · Questran-A · Questran-A, poeder voor orale suspensie 4 g
Belgium
Questran · Questran 4 g susp. buv. (pdr.) sachet
United Kingdom
Colestyramine · Colestyramine 4g oral powder sachets · Colestyramine 4g oral powder sachets sugar free · Colestyramine 500mg/5ml oral solution · Colestyramine 500mg/5ml oral suspension · Questran · Questran 4g oral powder sachets · Questran Light · Questran Light 4g oral powder sachets
Denmark
Colestyramin · Colestyramin "Orifarm" · Questran
Norway
Colestyramin orifarm · Colestyramin ratiopharm · Quantalan · Questran · Questran Loc
Luxembourg
QUESTRAN
Finland
Colestyramin-Ratiopharm · Questran · Resincolestiramina
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙